Rethinking
Drug Discovery

ABOUT US

Elix, Inc. is an AI drug discovery company with the mission of “Rethinking Drug Discovery.”

In addition to talented AI researchers and engineers, many of the team members have Ph.D. degrees and come from different specialities such as chemistry, biology and physics. Elix is professionally and culturally diverse, with members coming from more than 10 different countries.

Since Elixʼs foundation, English has been the official language of our team in anticipation of global expansion.

about

OUR
BUSINESS

Our clients are mainly from pharmaceutical companies and academia.

AI Drug Discovery

We provide an AI drug discovery platform, Elix DiscoveryTM.
Elix DiscoveryTM is the only all-in-one AI drug discovery platform that provides a variety of AI models, intuitive GUI, implementation support and consulting, and expert knowledge for AI drug discovery.

Major Functions

  • Activity prediction, physicochemical property prediction, ADMET prediction
  • Molecular design
  • Retrosynthesis analysis (currently only for collaborative research)
  • and more

Here are some of our major AI drug discovery partners

  • astellas
  • shionogi
  • kaken
  • eisai
  • riken
  • kyoto univ
  • And five other pharmaceutical companies

Our Partners

We are working together with companies and research institutes in a wide range of industries towards problem solving and value creation.

  • Corporate Partners

    • Astellas Pharma Inc.
    • shionogi
    • kaken
    • eisai
    • And five other pharmaceutical companies

  • Research Institutes and Universities

    • riken
    • kyoto univ.
    • Institute of Marerials Research and Engine
  • Partners

    • block buster tokyo
    • nvidea
    • DeNA
    • SEEDSUPPLY

CAREERS

We are actively hiring research engineers for our business expansion!
You are most welcomed if you have experiences in machine learning or if you have Ph.D. in computer science, chemistry, biology, or equivalent practical skills and strong interests in AI drug discovery!
In addition, due to the increasing importance of specialized knowledge and experience in drug discovery, we would love to have people from the pharmaceutical industries!